Inicio › Cáncer de próstata › Wisconsin

Ensayos clínicos de Cáncer de próstata en Wisconsin

47 estudios sobre Cáncer de próstata buscan participantes en Wisconsin.

Ciudades en Wisconsin

Texto oficial del estudio (inglés)

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
Marshfield Medical Center-EC Cancer Center, Eau Claire
University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
y 13 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 13 nov 2026 · NCT04423211

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 12 nov 2026 · NCT05691465

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Marshfield Medical Center-EC Cancer Center, Eau Claire
y 25 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03866382

The Vanguard Study: Testing a New Way to Screen for Cancer

Zablocki Veterans Administration Medical Center, Milwaukee

ReclutandoSe aceptan voluntarios sanos

Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898

WATER IV PCa (AS Sub-study)

Advocate Aurora Research Institute, Sheboygan

Reclutando

Edades de 45 en adelante · Hombres · Actualizado el 6 nov 2026 · NCT07650448

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

University of Wisconsin-Madison, Madison

ReclutandoEstudio observacional

Edades de 18 en adelante · Hombres · Actualizado el 6 nov 2026 · NCT06141993

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
y 50 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Marshfield Medical Center-Marshfield, Marshfield
Froedtert Menomonee Falls Hospital, Menomonee Falls
Medical College of Wisconsin, Milwaukee
y 2 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06632977

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Froedtert Menomonee Falls Hospital, Menomonee Falls
y 4 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT07200830

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
y 26 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 3 nov 2026 · NCT06931340

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

University Hospital and UW Health Clinics ( Site 0065), Madison
Medical College of Wisconsin ( Site 0008), Milwaukee

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 30 oct 2026 · NCT06925737

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

University of Wisconsin Carbone Cancer Center, Madison
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee

ReclutandoFase 1

Edades de 18 a 100 · Hombres · Actualizado el 29 oct 2026 · NCT05519449

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
y 36 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 23 oct 2026 · NCT05946213

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

University of Wisconsin-Madison, Madison

ReclutandoEstudio observacional

Edades de 18 en adelante · Hombres · Actualizado el 22 oct 2026 · NCT04489719

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

University of Wisconsin, Madison

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07103018

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Medical College of Wisconsin ( Site 0020), Milwaukee

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06136650

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06582017

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Medical College of Wisconsin, Milwaukee

ReclutandoFase 3

Edades de 18 a 100 · Hombres · Actualizado el 15 oct 2026 · NCT06855277

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT07028853

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Mayo Clinic Health System-Eau Claire, Eau Claire
Mayo Clinic Health System-Franciscan Healthcare, La Crosse

Reclutando

Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT06325046

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Langlade Hospital and Cancer Center, Antigo
Marshfield Medical Center-EC Cancer Center, Eau Claire
Marshfield Medical Center-Marshfield, Marshfield
y 14 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 8 oct 2026 · NCT03678025

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Wisconsin, Carbone Cancer Center, Madison

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT05919264

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Wisconsin Carbone Cancer Center, Madison

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

PET/CT Characterization of Treatment Resistance

University of Wisconsin, Madison

Reclutando

Edades de 18 en adelante · Hombres · Actualizado el 1 oct 2026 · NCT05647564

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Medical College Of Wisconsin, Milwaukee

ReclutandoFase 2/3

Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06780670

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT04038502

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Carbone Cancer Center University of Wisconsin-Madison, Madison

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 15 sept 2026 · NCT06150417

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

University of Wisconsin, Madison

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

Froedtert & the Medical College of Wisconsin, Milwaukee

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 9 sept 2026 · NCT07226713

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

UW Health Carbone Cancer Center, Madison

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 3 sept 2026 · NCT07005154

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

University of Wisconsin Carbone Cancer Center, Madison

ReclutandoEstudio observacional

Edades de 18 en adelante · Hombres · Actualizado el 27 ago 2026 · NCT07050433

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

University of Wisconsin Carbone Cancer Center-Madison, Madison

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 21 ago 2026 · NCT06844383

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Froedtert Hospital, Milwaukee

Reclutando

Edades de 65 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT07227077

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Medical College of Wisconsin, Milwaukee

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 31 jul 2026 · NCT06613100

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
Marshfield Medical Center-EC Cancer Center, Eau Claire
y 10 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

University of Wisconsin Carbone Cancer Center, Madison

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 9 jul 2026 · NCT05413421

Integrated Cancer Repository for Cancer Research

Bellin Memorial Hospital, Green Bay

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699

Using FAPI PET/MRI to Evaluate Prostate Cancer

University of Wisconsin, Madison

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jun 2026 · NCT06675357

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

University of Wisconsin Carbone Cancer Center, Madison

ReclutandoEstudio observacional

Edades de 21 en adelante · Hombres · Actualizado el 22 may 2026 · NCT03151629

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.